Deep Blue Medical this week introduced that it has obtained FDA clearance for its T-Line Hernia Mesh.
The T-Line Hernia Mesh presents superior anchoring power and eliminates a key level of failure for standard mesh fixation, which is the mesh, suture, tissue interface that may result in mesh migration, contraction and failure.
Deep Blue’s hernia mesh is large-pore and mid-weight and the extensions have 15 instances extra floor space than conventional sutures and act just like how snowshoes stop sinking in snow, in accordance with the corporate.
T-Line’s mesh extensions can face up to important stomach pressures as much as 50 N/cm of stress.
“Stitching a bit of every extension into the stomach wall, in lieu of conventional sutures, considerably will increase mesh anchoring power and thus the sturdiness of the restore,” Deep Blue founder Howard Levinson stated in a news release. “We consider this strategy will significantly enhance affected person outcomes with out necessitating important modifications to present surgical apply.”
The corporate expects to clinically launch the product in chosen websites in Q3 this yr.